Park, Jae-Il

Telomerase modulates Wnt signalling by association with target gene chromatin

Park, J.-I., Venteicher, A. S., Hong, J. Y., Choi, J., Jun, S., Shkreli, M., Chang, W., Meng, Z., Cheung, P., Ji, H., et al. (2009) · Nature

Wnt/β-catenin signaling in development and cancerTelomeres, Telomerase, and Senescence

Cited by 707

Multiple roles of phosphoinositide-specific phospholipase C isozymes

Suh, P.-G., Park, J.-I., Manzoli, L., Cocco, L., Peak, J. C., Katan, M., Fukami, K., Kataoka, T., Yun, S.-U., & Ryu, S.-H. (2008) · BMB Reports

Protein Kinase Regulation and GTPase SignalingPI3K/AKT/mTOR signaling in cancer

Cited by 501

PTPN14 is required for the density-dependent control of YAP1

Wang, W., Huang, J., Wang, X., Yuan, J., Li, X., Feng, L., Park, J.-I., & Chen, J. (2012) · Genes & Development

Hippo pathway signaling and YAP/TAZProtein Tyrosine Phosphatases

Cited by 195

Wnt signaling in liver regeneration, disease, and cancer

Zou, G., & Park, J.-I. (2023) · Clinical and Molecular Hepatology

Wnt/β-catenin signaling in development and cancerLiver physiology and pathology

Cited by 64

A novel modified RANKL variant can prevent osteoporosis by acting as a vaccine and an inhibitor

Ko, Y. J., Sohn, H. M., Jang, Y., Park, M., Kim, B., Kim, B., Park, J., Hyun, H., Jeong, B., Hong, C., et al. (2021) · Clinical and Translational Medicine

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 23